Fluorescence Immunity Diabetes-Renal-Injury Tests (FID-RIT) are diagnostic tests used to detect the presence of kidney injury in patients with diabetes. FID-RIT combines fluorescence microscopy and immunohistochemistry to identify the localization and distribution of inflammatory cells and proteins in renal tissue. The test measures the levels of various biomarkers and antibodies that are associated with renal injury, including IgG, IgM, C3, fibrinogen, albumin, and collagen. The results of FID-RIT can be used to diagnose renal injury in diabetic patients at an early stage, allowing for prompt medical intervention and improved outcomes. The test is non-invasive, quick, and has a high degree of sensitivity and specificity.
Fluorescence Immunity Diabetes-Renal-Injury Test (FID-RIT) diagnoses kidney injury by analyzing the localization and distribution of inflammatory cells and proteins in renal tissue, detecting the levels of various biomarkers and antibodies associated with renal injury.
The amount of time it takes to perform Fluorescence Immunity Diabetes-Renal-Injury Test (FID-RIT) varies, but it typically takes a few hours to complete. This depends on the specific laboratory and resources available.